Glaxo Sees More Competitive Shifts by U.S. Payers

Feb. 5 (Bloomberg) -- Simon Dingemans, chief financial officer at GlaxoSmithKline Plc, discusses the drugmaker's growth, new products and maintaining competitiveness in the U.S. He speaks with Bloomberg's Makiko Kitamura in London. (Source: Bloomberg)

Making the Economic Case for the Fed to Raise Rates
02:24 - Steven Ricchiuto, chief economist at Mizuho Securities, and Bob Michele, global chief investment officer at JPMorgan Asset Management, look at U.S. economic growth and the Federal Reserve's rate hike path. They speak on "Bloomberg ‹GO›." (Source: Bloomberg)
  • What to Watch for in Apple's Results
  • McDonald's Misses on Same-Store Sales Growth
  • Investors Find Comfort in a Government Divided